Skip to Content

Published on April 20, 2017

Palos Health, Loyola Medicine Announce Radiation Oncology Joint Venture

Center to Offer First MRI-guided Radiation Therapy in Illinois

Palos Health and Loyola Medicine today announced plans to establish a joint venture to offer radiation oncology services at Palos Health South Campus in Orland Park.

The joint venture, named South Campus Partners, LLC, will strengthen the exclusive academic partner affiliation between Loyola and Palos and enhance delivery of world-class ambulatory care in the southwest suburbs.

“With this joint venture, Palos patients will have even greater access to Loyola’s academic expertise right in our neighborhood,” said Terrence Moisan, MD, president & CEO of Palos. “Our goal is to develop the Palos Health South Campus into a regional destination for outpatient care.”

Palos Health is a fully integrated, community-based health care system consisting of Palos Hospital, Palos Medical Group, Palos South Campus in Orland Park and Palos Home Care and Hospice.

“Loyola is excited to expand our existing oncology program and services to include state-of-the-art Radiation Oncology services on Palos’ south campus,” said Daniel J. Post, regional executive vice president for strategy and business development, Trinity Health Illinois. “We are committed to partnering with Palos to offer multi-disciplinary, collaborative oncology care close to home.”

Trinity Health Illinois is a regional system of Trinity Health – one of the nation’s largest healthcare systems with 93 hospitals in 22 states – that includes Loyola University Health System.

South Campus Partners, LLC, will be governed by a board with equal representation from Loyola and Palos.

Radiation oncology services at the Loyola Center for Cancer Care & Research at Palos Health South Campus, 15300 West Avenue in Orland Park, will open in the summer of 2018 and be located in 13,000-square-feet of newly constructed space offering improved patient access and additional physician office space.

Raymond B. Wynn, MD, FACR, an internationally known radiation oncologist at Loyola, has been selected as the medical director of radiation oncology for this new facility.

The unit will feature the first radiation therapy system in Illinois that’s guided in real time by MRI imaging. During radiation therapy, tissues move when a patient breathes. The MRI-guided system, called MRIdian®, can image and treat cancer patients simultaneously with the ability to precisely target moving tumors during treatment while avoiding surrounding tissue. 

“The ability to see, adapt and treat with MRI-guided radiotherapy will benefit our patients in countless ways,” said William Small, Jr., MD, FACRO, FACR, FASTRO, chair of Loyola’s department of radiation oncology.

Nearly two years ago, Loyola and Palos entered into a clinical affiliation agreement. Since then, affiliation developments have included:

  • A 24/7 telestroke program allows Loyola stroke specialists to assess Palos patients remotely via a telemedicine robot.
  • The Loyola Center for Cancer Care & Research at Palos Health South Campus, which provides access to Loyola oncology experts, experimental new drugs and clinical trials, as well as an on-site chemotherapy infusion center.
  • Streamlined trauma transfers and subspecialty referrals from Palos to Loyola.
  • Educational programming for Palos physicians by teleconferenced grand rounds and continuing medical education courses.
  • Palos and Loyola now have compatible electronic medical records systems making it easier for clinicians to access medical records across both systems.

As with previous steps in this innovative partnership, Palos will remain independent. Each organization will maintain its own culture, mission and commitment to the community, and financial and organizational structures will remain separate. 

Health eNewsletter Sign Up

Palos Health's monthly Health eNewsletter includes information about upcoming events, classes and other important health-related news. Join your friends, colleagues and neighbors by completing the form below to subscribe. We respect your privacy and will not sell or share your information with anyone else.

Sorry, you must have JavaScript enabled to sign up for newsletters.